Compound details
Glaucine
| Compound ID | CDAMM00560 |
|---|---|
| Common name | Glaucine | IUPAC name | 1,2,9,10-tetramethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline |
| Molecular formula | C21H25NO4 |
| Retention time | 10.05 |
|---|---|
| Adduct | [2M+Na]+ |
| Actual mz | 733.336 | Theoretical mz | 733.345 |
| Error | 12.43 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.2416 |
| Inchi key | RUZIUYOSRDWYQF-GGYSOQFKNA-N |
|---|---|
| Smiles | O(C=1C=C2C=3C(OC)=C(OC)C=C4C3C(N(C)CC4)CC2=CC1OC)C |
| Superclass | Alkaloids and derivatives |
| Class | Aporphines |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P43681 | CHRNA4 | Neuronal acetylcholine receptor; alpha4/beta2 | T70967 | SwissTargetPrediction and SEA |
| P00533 | EGFR | Epidermal growth factor receptor erbB1 | T59328 | SwissTargetPrediction |
| P22303 | ACHE | Acetylcholinesterase | T30082 | SEA |
| Q12809 | KCNH2 | HERG | T20251 | SwissTargetPrediction |
| P36544 | CHRNA7 | Neuronal acetylcholine receptor protein alpha-7 subunit | T34429 | SwissTargetPrediction |
| P30542 | ADORA1 | Adenosine A1 receptor | T92072 | SwissTargetPrediction |
| Q99720 | SIGMAR1 | Sigma opioid receptor | T46360 | SwissTargetPrediction and SEA |
| P41594 | GRM5 | Metabotropic glutamate receptor 5 | T99347 | SwissTargetPrediction |
| P21917 | DRD4 | Dopamine D4 receptor | T24983 | SwissTargetPrediction |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| P14416 | DRD2 | Dopamine D2 receptor | T67162 | SwissTargetPrediction and SEA |
| P27487 | DPP4 | Dipeptidyl peptidase IV | T31391 | SEA |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SwissTargetPrediction |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SEA |
| P28223 | HTR2A | Serotonin 2a (5-HT2a) receptor | T32060 | SwissTargetPrediction and SEA |
| P28335 | HTR2C | Serotonin 2c (5-HT2c) receptor | T83813 | SwissTargetPrediction |
| P31645 | SLC6A4 | Serotonin transporter (by homology) | T27812 | SwissTargetPrediction |
| Q05940 | SLC18A2 | Synaptic vesicular amine transporter (by homology) | T48873 | SEA |
| P41595 | HTR2B | Serotonin 2b (5-HT2b) receptor | T31204 | SwissTargetPrediction and SEA |
| P08913 | ADRA2A | Alpha-2a adrenergic receptor | T11448 | SwissTargetPrediction and SEA |
| P28222 | HTR1B | Serotonin 1b (5-HT1b) receptor | T07806 | SwissTargetPrediction |
| P28221 | HTR1D | Serotonin 1d (5-HT1d) receptor | T11072 | SwissTargetPrediction |
| P08588 | ADRB1 | Beta-1 adrenergic receptor | T44068 | SwissTargetPrediction |
| P08908 | HTR1A | Serotonin 1a (5-HT1a) receptor | T78709 | SwissTargetPrediction and SEA |
| P34969 | HTR7 | Serotonin 7 (5-HT7) receptor | T79062 | SwissTargetPrediction and SEA |
| P50406 | HTR6 | Serotonin 6 (5-HT6) receptor | T16691 | SwissTargetPrediction |
| Q01959 | SLC6A3 | Dopamine transporter | T55959 | SwissTargetPrediction |
| P15538 | CYP11B1 | Cytochrome P450 11B1 | T84621 | SwissTargetPrediction |
| P19099 | CYP11B2 | Cytochrome P450 11B2 | T59056 | SwissTargetPrediction |
| Q5T7T8 | COX1 | Prostaglandin G/H synthase 1 | T60529 | SwissTargetPrediction |
| P35354 | PTGS2 | Cyclooxygenase-2 | T66665 | SwissTargetPrediction |
| P07101 | TH | Tyrosine 3-hydroxylase | T62390 | SwissTargetPrediction and SEA |
| O60885 | BRD4 | Bromodomain-containing protein 4 | T00407 | SwissTargetPrediction |
| P25440 | BRD2 | Bromodomain-containing protein 2 | T86597 | SwissTargetPrediction |
| Q15059 | BRD3 | Bromodomain-containing protein 3 | T42048 | SwissTargetPrediction |
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SwissTargetPrediction |
| P25021 | HRH2 | Histamine H2 receptor | T30985 | SwissTargetPrediction |
| O14842 | FFAR1 | Free fatty acid receptor 1 | T25608 | SwissTargetPrediction |
| P49137 | MAPKAPK2 | MAP kinase-activated protein kinase 2 | T21307 | SwissTargetPrediction |
| P13726 | F3 | Coagulation factor VII/tissue factor | T72702 | SEA |
| P35869 | AHR | Aryl hydrocarbon receptor | T23666 | SwissTargetPrediction |
| Q9UM73 | ALK | ALK tyrosine kinase receptor | T56418 | SwissTargetPrediction |
| P35462 | DRD3 | Dopamine D3 receptor | T02551 | SwissTargetPrediction and SEA |
| P21728 | DRD1 | Dopamine D1 receptor | T22118 | SwissTargetPrediction and SEA |
| P21918 | DRD5 | Dopamine D5 receptor | T46828 | SwissTargetPrediction and SEA |
| P18825 | ADRA2C | Adrenergic receptor alpha-2 | T01777 | SwissTargetPrediction |
| P33527 | ABCC1 | Multidrug resistance-associated protein 1 | T11288 | SEA |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SwissTargetPrediction and SEA |
| P35372 | OPRM1 | Mu opioid receptor | T47768 | SwissTargetPrediction |
| P25100 | ADRA1D | Alpha-1d adrenergic receptor | T53381 | SwissTargetPrediction |
| P35368 | ADRA1B | Alpha-1b adrenergic receptor | T29500 | SwissTargetPrediction |
| P42345 | MTOR | Serine/threonine-protein kinase mTOR | T75243 | SwissTargetPrediction |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| O60674 | JAK2 | Tyrosine-protein kinase JAK2 | T08391 | SwissTargetPrediction |
| P36888 | FLT3 | Tyrosine-protein kinase receptor FLT3 | T74312 | SwissTargetPrediction |
| O14965 | AURKA | Serine/threonine-protein kinase Aurora-A | T87675 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P62942 | FKBP1A | FK506-binding protein 1A | T76059 | SEA |
| Q08499 | PDE4D | Phosphodiesterase 4D | T02001 | SwissTargetPrediction |
| P43116 | PTGER2 | Prostanoid EP2 receptor | T38529 | SwissTargetPrediction |
| P49356 | FNTB | Farnesyl protein transferase | T13127 | SwissTargetPrediction |
| P35348 | ADRA1A | Alpha-1a adrenergic receptor | T92609 | SwissTargetPrediction |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | T70977 | SwissTargetPrediction |
| P32246 | CCR1 | C-C chemokine receptor type 1 | T16016 | SwissTargetPrediction |
| Q5S007 | LRRK2 | Leucine-rich repeat serine/threonine-protein kinase 2 | T08123 | SwissTargetPrediction |
| P49810 | PSEN2 | Gamma-secretase | T99204 | SwissTargetPrediction |
| P08581 | MET | Hepatocyte growth factor receptor | T40474 | SwissTargetPrediction |
| P36897 | TGFBR1 | TGF-beta receptor type I | T53389 | SwissTargetPrediction |
| Q14432 | PDE3A | Phosphodiesterase 3 | T88975 | SwissTargetPrediction |
| P12931 | SRC | Tyrosine-protein kinase SRC | T85943 | SwissTargetPrediction |
| P30411 | BDKRB2 | Bradykinin B2 receptor | T23714 | SwissTargetPrediction |
| O00444 | PLK4 | Serine/threonine-protein kinase PLK4 | T71374 | SwissTargetPrediction |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction |
| P47898 | HTR5A | Serotonin 5a (5-HT5a) receptor | T15571 | SwissTargetPrediction and SEA |
| P18089 | ADRA2B | Alpha-2b adrenergic receptor | T41580 | SwissTargetPrediction |
| Q9BPW0 | PPP5C | Serine/threonine-protein phosphatase | T04123 | SwissTargetPrediction |
| Q92793 | CREBBP | CREB-binding protein/p53 | T03634 | SwissTargetPrediction |
| P49336 | CDK8 | Cell division protein kinase 8 | T10822 | SwissTargetPrediction |
| O76074 | PDE5A | Phosphodiesterase 5A | T07663 | SwissTargetPrediction |
| P78527 | PRKDC | DNA-dependent protein kinase | T81735 | SwissTargetPrediction |
| P27815 | PDE4A | Phosphodiesterase 4A | T61744 | SwissTargetPrediction |
| Q96GD4 | AURKB | Serine/threonine-protein kinase Aurora-B | T46781 | SwissTargetPrediction |
| P30536 | TSPO | Translocator protein (by homology) | T75440 | SwissTargetPrediction and SEA |
| P16234 | PDGFRA | Platelet-derived growth factor receptor | T53524 | SwissTargetPrediction |
| P53609 | PGGT1B | Geranylgeranyl transferase type I | T76396 | SwissTargetPrediction |
| Q9UKP6 | UTS2R | Urotensin II receptor | T49072 | SwissTargetPrediction |
| Q13370 | PDE3B | Phosphodiesterase 3B | T21357 | SwissTargetPrediction |
| O00408 | PDE2A | Phosphodiesterase 2A | T77400 | SwissTargetPrediction |
| Q15746 | MYLK | Myosin light chain kinase, smooth muscle | T97141 | SwissTargetPrediction |
| Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | T53251 | SEA |
| Q15759 | MAPK11 | MAP kinase p38 beta | T55729 | SwissTargetPrediction |
| Q92952 | KCNN1 | Small conductance calcium-activated potassium channel protein 1 | T11911 | SEA |
| Q9UGI6 | KCNN3 | Small conductance calcium-activated potassium channel protein 3 | T04388 | SEA |
| Q08493 | PDE4C | Phosphodiesterase 4C | T12081 | SwissTargetPrediction |
| P19438 | TNFRSF1A | Tumor necrosis factor receptor R1 | T86552 | SwissTargetPrediction |
| O60285 | NUAK1 | NUAK family SNF1-like kinase 1 | T21653 | SwissTargetPrediction |
| Q9Y3Q4 | HCN4 | Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | T30286 | SEA |
| Q9H9B1 | EHMT1 | Histone-lysine N-methyltransferase, H3 lysine-9 specific 5 | T39996 | SEA |
| Q6DWJ6 | GPR139 | Probable G-protein coupled receptor 139 | T84439 | SwissTargetPrediction |
| Q15822 | CHRNA2 | Neuronal acetylcholine receptor; alpha2/beta2 | T55815 | SEA |
| Q9UIF9 | BAZ2A | Bromodomain adjacent to zinc finger domain protein 2A | T95682 | SwissTargetPrediction |
| O75884 | RBBP9 | Putative hydrolase RBBP9 | T12084 | SEA |
| Q9H2S1 | KCNN2 | Small conductance calcium-activated potassium channel protein 2 | T86271 | SEA |
| P54750 | PDE1A | Phosphodiesterase 1A | T81637 | SEA |
| Q9UIF8 | BAZ2B | Bromodomain adjacent to zinc finger domain protein 2B | T15745 | SwissTargetPrediction |
| O95551 | TDP2 | Tyrosyl-DNA phosphodiesterase 2 | T04696 | SEA |
| P17787 | CHRNB2 | Nicotinic acetylcholine receptor alpha2/beta2 | T82543 | SEA |
| P51843 | NR0B1 | Orphan nuclear receptor DAX-1 | T23191 | SEA |
| Q9UJ67 | APAF1 | Caterpiller protein 1.1 | T08499 | SEA |
| O75751 | EMTH | Organic cation transporter 3 | T55948 | SEA |
| O15439 | ABCC4 | Multidrug resistance protein 4 | T39919 | SEA |
| Q96LD8 | SENP8 | Deneddylase-1 | T13928 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T70967 | DI0029 | Aneurysm/dissection | [ICD-11: BD50] | P43681 | CHRNA4 |
| T70967 | DI0191 | Hypertensive crisis | [ICD-11: BA03] | P43681 | CHRNA4 |
| T70967 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P43681 | CHRNA4 |
| T59328 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00533 | EGFR |
| T59328 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00533 | EGFR |
| T59328 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P00533 | EGFR |
| T59328 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P00533 | EGFR |
| T59328 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00533 | EGFR |
| T59328 | DI0238 | Lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P00533 | EGFR |
| T59328 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00533 | EGFR |
| T59328 | DI0420 | Unspecific body region injury | [ICD-11: ND56] | P00533 | EGFR |
| T30082 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P22303 | ACHE |
| T30082 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22303 | ACHE |
| T30082 | DI0282 | Myasthenia gravis | [ICD-11: 8C6Y] | P22303 | ACHE |
| T30082 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P22303 | ACHE |
| T30082 | DI0332 | Pediculosis | [ICD-11: 1G00] | P22303 | ACHE |
| T30082 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P22303 | ACHE |
| T20251 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q12809 | KCNH2 |
| T34429 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P36544 | CHRNA7 |
| T34429 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P36544 | CHRNA7 |
| T92072 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P30542 | ADORA1 |
| T46360 | DI0105 | Cough | [ICD-11: MD12] | Q99720 | SIGMAR1 |
| T99347 | DI0152 | Fragile X chromosome | [ICD-11: LD55] | P41594 | GRM5 |
| T99347 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P41594 | GRM5 |
| T24983 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21917 | DRD4 |
| T24983 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P21917 | DRD4 |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T67162 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P14416 | DRD2 |
| T67162 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P14416 | DRD2 |
| T67162 | DI0037 | Asthma | [ICD-11: CA23] | P14416 | DRD2 |
| T67162 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P14416 | DRD2 |
| T67162 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P14416 | DRD2 |
| T67162 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P14416 | DRD2 |
| T67162 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P14416 | DRD2 |
| T67162 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P14416 | DRD2 |
| T67162 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14416 | DRD2 |
| T67162 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P14416 | DRD2 |
| T67162 | DI0137 | Essential hypertension | [ICD-11: BA00] | P14416 | DRD2 |
| T67162 | DI0142 | Faecal incontinence | [ICD-11: ME07] | P14416 | DRD2 |
| T67162 | DI0156 | Gangrene | [ICD-11: MC85] | P14416 | DRD2 |
| T67162 | DI0166 | Glaucoma | [ICD-11: 9C61] | P14416 | DRD2 |
| T67162 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P14416 | DRD2 |
| T67162 | DI0185 | Hyperaemia | [ICD-11: 9A61-9B7Y] | P14416 | DRD2 |
| T67162 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P14416 | DRD2 |
| T67162 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P14416 | DRD2 |
| T67162 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | P14416 | DRD2 |
| T67162 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14416 | DRD2 |
| T67162 | DI0222 | Itching | [ICD-11: 1F28-1G07] | P14416 | DRD2 |
| T67162 | DI0264 | Migraine | [ICD-11: 8A80] | P14416 | DRD2 |
| T67162 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P14416 | DRD2 |
| T67162 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P14416 | DRD2 |
| T67162 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P14416 | DRD2 |
| T67162 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P14416 | DRD2 |
| T67162 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P14416 | DRD2 |
| T67162 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P14416 | DRD2 |
| T67162 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P14416 | DRD2 |
| T67162 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P14416 | DRD2 |
| T67162 | DI0396 | Substance abuse | [ICD-11: 6C40] | P14416 | DRD2 |
| T67162 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P14416 | DRD2 |
| T67162 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P14416 | DRD2 |
| T31391 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P27487 | DPP4 |
| T31391 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P27487 | DPP4 |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T32060 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P28223 | HTR2A |
| T32060 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P28223 | HTR2A |
| T32060 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P28223 | HTR2A |
| T32060 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P28223 | HTR2A |
| T32060 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P28223 | HTR2A |
| T32060 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28223 | HTR2A |
| T32060 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28223 | HTR2A |
| T83813 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P28335 | HTR2C |
| T83813 | DI0264 | Migraine | [ICD-11: 8A80] | P28335 | HTR2C |
| T83813 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P28335 | HTR2C |
| T83813 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P28335 | HTR2C |
| T83813 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28335 | HTR2C |
| T27812 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P31645 | SLC6A4 |
| T27812 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P31645 | SLC6A4 |
| T27812 | DI0087 | Chronic pain | [ICD-11: MG30] | P31645 | SLC6A4 |
| T27812 | DI0096 | concerning food/fluid intake symptom | [ICD-11: MG43] | P31645 | SLC6A4 |
| T27812 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P31645 | SLC6A4 |
| T27812 | DI0105 | Cough | [ICD-11: MD12] | P31645 | SLC6A4 |
| T27812 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P31645 | SLC6A4 |
| T27812 | DI0264 | Migraine | [ICD-11: 8A80] | P31645 | SLC6A4 |
| T27812 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P31645 | SLC6A4 |
| T27812 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P31645 | SLC6A4 |
| T27812 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P31645 | SLC6A4 |
| T48873 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q05940 | SLC18A2 |
| T48873 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | Q05940 | SLC18A2 |
| T48873 | DI0129 | Dystonic disorder | [ICD-11: 8A02] | Q05940 | SLC18A2 |
| T48873 | DI0137 | Essential hypertension | [ICD-11: BA00] | Q05940 | SLC18A2 |
| T48873 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | Q05940 | SLC18A2 |
| T31204 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P41595 | HTR2B |
| T31204 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41595 | HTR2B |
| T31204 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P41595 | HTR2B |
| T31204 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P41595 | HTR2B |
| T11448 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P08913 | ADRA2A |
| T11448 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P08913 | ADRA2A |
| T11448 | DI0396 | Substance abuse | [ICD-11: 6C40] | P08913 | ADRA2A |
| T07806 | DI0264 | Migraine | [ICD-11: 8A80] | P28222 | HTR1B |
| T07806 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28222 | HTR1B |
| T07806 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P28222 | HTR1B |
| T07806 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28222 | HTR1B |
| T11072 | DI0264 | Migraine | [ICD-11: 8A80] | P28221 | HTR1D |
| T11072 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28221 | HTR1D |
| T44068 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P08588 | ADRB1 |
| T44068 | DI0037 | Asthma | [ICD-11: CA23] | P08588 | ADRB1 |
| T44068 | DI0068 | Cardiac arrhythmia | [ICD-11: BC9Z] | P08588 | ADRB1 |
| T44068 | DI0071 | Central and peripheral nervous disease | [ICD-11: 8A04-8E7Z] | P08588 | ADRB1 |
| T44068 | DI0088 | Circulatory system disease | [ICD-11: BE2Z] | P08588 | ADRB1 |
| T44068 | DI0097 | Conduction disorder | [ICD-11: BC63] | P08588 | ADRB1 |
| T44068 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P08588 | ADRB1 |
| T44068 | DI0137 | Essential hypertension | [ICD-11: BA00] | P08588 | ADRB1 |
| T44068 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08588 | ADRB1 |
| T44068 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08588 | ADRB1 |
| T44068 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08588 | ADRB1 |
| T44068 | DI0264 | Migraine | [ICD-11: 8A80] | P08588 | ADRB1 |
| T44068 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | P08588 | ADRB1 |
| T44068 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P08588 | ADRB1 |
| T44068 | DI0434 | Ventricular tachyarrhythmia | [ICD-11: BC71] | P08588 | ADRB1 |
| T78709 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P08908 | HTR1A |
| T78709 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P08908 | HTR1A |
| T78709 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08908 | HTR1A |
| T78709 | DI0264 | Migraine | [ICD-11: 8A80] | P08908 | HTR1A |
| T78709 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P08908 | HTR1A |
| T79062 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P34969 | HTR7 |
| T79062 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P34969 | HTR7 |
| T79062 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P34969 | HTR7 |
| T79062 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P34969 | HTR7 |
| T79062 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P34969 | HTR7 |
| T79062 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P34969 | HTR7 |
| T79062 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P34969 | HTR7 |
| T16691 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P50406 | HTR6 |
| T16691 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P50406 | HTR6 |
| T55959 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q01959 | SLC6A3 |
| T55959 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | Q01959 | SLC6A3 |
| T55959 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | Q01959 | SLC6A3 |
| T55959 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q01959 | SLC6A3 |
| T55959 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q01959 | SLC6A3 |
| T55959 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q01959 | SLC6A3 |
| T84621 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P15538 | CYP11B1 |
| T84621 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P15538 | CYP11B1 |
| T59056 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P19099 | CYP11B2 |
| T60529 | DI0141 | Eye anterior segment structural developmental anomaly | [ICD-11: LA11] | Q5T7T8 | COX1 |
| T60529 | DI0145 | Female pelvic pain | [ICD-11: GA34] | Q5T7T8 | COX1 |
| T60529 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q5T7T8 | COX1 |
| T60529 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | Q5T7T8 | COX1 |
| T60529 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | Q5T7T8 | COX1 |
| T60529 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q5T7T8 | COX1 |
| T60529 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q5T7T8 | COX1 |
| T60529 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q5T7T8 | COX1 |
| T60529 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q5T7T8 | COX1 |
| T60529 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | Q5T7T8 | COX1 |
| T60529 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | Q5T7T8 | COX1 |
| T60529 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | Q5T7T8 | COX1 |
| T66665 | DI0087 | Chronic pain | [ICD-11: MG30] | P35354 | PTGS2 |
| T66665 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P35354 | PTGS2 |
| T66665 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P35354 | PTGS2 |
| T66665 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P35354 | PTGS2 |
| T66665 | DI0227 | Knee osteoarthritis | [ICD-11: FA01] | P35354 | PTGS2 |
| T66665 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35354 | PTGS2 |
| T66665 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35354 | PTGS2 |
| T66665 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P35354 | PTGS2 |
| T66665 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | P35354 | PTGS2 |
| T62390 | DI0019 | Adrenomedullary hyperfunction | [ICD-11: 5A75] | P07101 | TH |
| T62390 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P07101 | TH |
| T86597 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P25440 | BRD2 |
| T42048 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q15059 | BRD3 |
| T42048 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q15059 | BRD3 |
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T30985 | DI0161 | Gastro-oesophageal reflux disease | [ICD-11: DA22] | P25021 | HRH2 |
| T30985 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P25021 | HRH2 |
| T30985 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P25021 | HRH2 |
| T25608 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | O14842 | FFAR1 |
| T21307 | DI0011 | Acute laryngitis/tracheitis | [ICD-11: CA05] | P49137 | MAPKAPK2 |
| T21307 | DI0181 | Hidradenitis suppurativa | [ICD-11: ED92] | P49137 | MAPKAPK2 |
| T21307 | DI0269 | Monogenic autoinflammatory syndrome | [ICD-11: 4A60] | P49137 | MAPKAPK2 |
| T21307 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P49137 | MAPKAPK2 |
| T21307 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P49137 | MAPKAPK2 |
| T21307 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P49137 | MAPKAPK2 |
| T21307 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P49137 | MAPKAPK2 |
| T72702 | DI0075 | Cervical cancer | [ICD-11: 2C77] | P13726 | F3 |
| T23666 | DI0351 | Psoriasis | [ICD-11: EA90] | P35869 | AHR |
| T23666 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P35869 | AHR |
| T56418 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q9UM73 | ALK |
| T56418 | DI0251 | Mature T-cell lymphoma | [ICD-11: 2A90] | Q9UM73 | ALK |
| T56418 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | Q9UM73 | ALK |
| T02551 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P35462 | DRD3 |
| T02551 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35462 | DRD3 |
| T22118 | DI0003 | Abortion | [ICD-11: JA00] | P21728 | DRD1 |
| T22118 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21728 | DRD1 |
| T22118 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P21728 | DRD1 |
| T22118 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21728 | DRD1 |
| T46828 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21918 | DRD5 |
| T01777 | DI0166 | Glaucoma | [ICD-11: 9C61] | P18825 | ADRA2C |
| T01777 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P18825 | ADRA2C |
| T01777 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P18825 | ADRA2C |
| T01777 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18825 | ADRA2C |
| T01777 | DI0310 | Ocular disease | [ICD-11: N.A.] | P18825 | ADRA2C |
| T01777 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18825 | ADRA2C |
| T11288 | DI0167 | Gout | [ICD-11: FA25] | P33527 | ABCC1 |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T47768 | DI0013 | Acute pain | [ICD-11: MG31] | P35372 | OPRM1 |
| T47768 | DI0059 | Bowel habit change | [ICD-11: ME05] | P35372 | OPRM1 |
| T47768 | DI0087 | Chronic pain | [ICD-11: MG30] | P35372 | OPRM1 |
| T47768 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P35372 | OPRM1 |
| T47768 | DI0105 | Cough | [ICD-11: MD12] | P35372 | OPRM1 |
| T47768 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35372 | OPRM1 |
| T47768 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P35372 | OPRM1 |
| T47768 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P35372 | OPRM1 |
| T47768 | DI0228 | Large intestine motility disorder | [ICD-11: DB32] | P35372 | OPRM1 |
| T47768 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P35372 | OPRM1 |
| T47768 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35372 | OPRM1 |
| T47768 | DI0349 | Pruritus | [ICD-11: EC90] | P35372 | OPRM1 |
| T47768 | DI0374 | Sensation disturbance | [ICD-11: MB40] | P35372 | OPRM1 |
| T53381 | DI0166 | Glaucoma | [ICD-11: 9C61] | P25100 | ADRA1D |
| T53381 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P25100 | ADRA1D |
| T53381 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P25100 | ADRA1D |
| T53381 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P25100 | ADRA1D |
| T53381 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P25100 | ADRA1D |
| T53381 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P25100 | ADRA1D |
| T29500 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P35368 | ADRA1B |
| T29500 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P35368 | ADRA1B |
| T29500 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P35368 | ADRA1B |
| T29500 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P35368 | ADRA1B |
| T29500 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35368 | ADRA1B |
| T75243 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P42345 | MTOR |
| T75243 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | P42345 | MTOR |
| T75243 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P42345 | MTOR |
| T75243 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P42345 | MTOR |
| T75243 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P42345 | MTOR |
| T75243 | DI0413 | Transplant rejection | [ICD-11: NE84] | P42345 | MTOR |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T08391 | DI0039 | Atopic eczema | [ICD-11: EA80] | O60674 | JAK2 |
| T08391 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60674 | JAK2 |
| T08391 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | O60674 | JAK2 |
| T08391 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | O60674 | JAK2 |
| T74312 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P36888 | FLT3 |
| T74312 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P36888 | FLT3 |
| T74312 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P36888 | FLT3 |
| T74312 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P36888 | FLT3 |
| T74312 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P36888 | FLT3 |
| T74312 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P36888 | FLT3 |
| T74312 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P36888 | FLT3 |
| T74312 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P36888 | FLT3 |
| T87675 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O14965 | AURKA |
| T87675 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14965 | AURKA |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T76059 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P62942 | FKBP1A |
| T76059 | DI0349 | Pruritus | [ICD-11: EC90] | P62942 | FKBP1A |
| T76059 | DI0413 | Transplant rejection | [ICD-11: NE84] | P62942 | FKBP1A |
| T02001 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | Q08499 | PDE4D |
| T38529 | DI0003 | Abortion | [ICD-11: JA00] | P43116 | PTGER2 |
| T38529 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P43116 | PTGER2 |
| T38529 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P43116 | PTGER2 |
| T38529 | DI0166 | Glaucoma | [ICD-11: 9C61] | P43116 | PTGER2 |
| T38529 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P43116 | PTGER2 |
| T38529 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P43116 | PTGER2 |
| T38529 | DI0413 | Transplant rejection | [ICD-11: NE84] | P43116 | PTGER2 |
| T13127 | DI0342 | Premature ageing appearance | [ICD-11: LD2B] | P49356 | FNTB |
| T92609 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P35348 | ADRA1A |
| T92609 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P35348 | ADRA1A |
| T70977 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | P49841 | GSK3B |
| T16016 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P32246 | CCR1 |
| T16016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P32246 | CCR1 |
| T08123 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q5S007 | LRRK2 |
| T99204 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P49810 | PSEN2 |
| T99204 | DI0380 | Shoulder lesion | [ICD-11: FB53] | P49810 | PSEN2 |
| T99204 | DI0390 | Soft tissue disorder | [ICD-11: FB56] | P49810 | PSEN2 |
| T40474 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P08581 | MET |
| T53389 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | P36897 | TGFBR1 |
| T53389 | DI0238 | Lung cancer | [ICD-11: 2C25] | P36897 | TGFBR1 |
| T88975 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | Q14432 | PDE3A |
| T88975 | DI0037 | Asthma | [ICD-11: CA23] | Q14432 | PDE3A |
| T88975 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q14432 | PDE3A |
| T88975 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | Q14432 | PDE3A |
| T85943 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P12931 | SRC |
| T85943 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P12931 | SRC |
| T85943 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P12931 | SRC |
| T85943 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P12931 | SRC |
| T23714 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | P30411 | BDKRB2 |
| T71374 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | O00444 | PLK4 |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T15571 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P47898 | HTR5A |
| T41580 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18089 | ADRA2B |
| T03634 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q92793 | CREBBP |
| T03634 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q92793 | CREBBP |
| T03634 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q92793 | CREBBP |
| T03634 | DI0399 | Systemic sclerosis | [ICD-11: 4A42] | Q92793 | CREBBP |
| T10822 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P49336 | CDK8 |
| T10822 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P49336 | CDK8 |
| T07663 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | O76074 | PDE5A |
| T07663 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | O76074 | PDE5A |
| T07663 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | O76074 | PDE5A |
| T07663 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | O76074 | PDE5A |
| T81735 | DI0360 | Rectum cancer | [ICD-11: 2B92] | P78527 | PRKDC |
| T81735 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P78527 | PRKDC |
| T61744 | DI0037 | Asthma | [ICD-11: CA23] | P27815 | PDE4A |
| T46781 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q96GD4 | AURKB |
| T46781 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q96GD4 | AURKB |
| T75440 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P30536 | TSPO |
| T75440 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P30536 | TSPO |
| T75440 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P30536 | TSPO |
| T75440 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P30536 | TSPO |
| T75440 | DI0271 | Mood/affect symptom | [ICD-11: MB24] | P30536 | TSPO |
| T75440 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P30536 | TSPO |
| T53524 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P16234 | PDGFRA |
| T53524 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P16234 | PDGFRA |
| T53524 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P16234 | PDGFRA |
| T76396 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P53609 | PGGT1B |
| T49072 | DI0037 | Asthma | [ICD-11: CA23] | Q9UKP6 | UTS2R |
| T77400 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | O00408 | PDE2A |
| T77400 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | O00408 | PDE2A |
| T77400 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | O00408 | PDE2A |
| T77400 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | O00408 | PDE2A |
| T97141 | DI0127 | Duodenal ulcer | [ICD-11: DA63] | Q15746 | MYLK |
| T53251 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q96KQ7 | EHMT2 |
| T53251 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q96KQ7 | EHMT2 |
| T53251 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q96KQ7 | EHMT2 |
| T55729 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q15759 | MAPK11 |
| T55729 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q15759 | MAPK11 |
| T11911 | DI0285 | Myelopathy | [ICD-11: 8B42] | Q92952 | KCNN1 |
| T04388 | DI0285 | Myelopathy | [ICD-11: 8B42] | Q9UGI6 | KCNN3 |
| T86552 | DI0060 | Brain cancer | [ICD-11: 2A00] | P19438 | TNFRSF1A |
| T86552 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P19438 | TNFRSF1A |
| T39996 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q9H9B1 | EHMT1 |
| T39996 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9H9B1 | EHMT1 |
| T84439 | DI0377 | Sex development malformative disorder | [ICD-11: LD2A] | Q6DWJ6 | GPR139 |
| T55815 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | Q15822 | CHRNA2 |
| T55815 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | Q15822 | CHRNA2 |
| T55815 | DI0166 | Glaucoma | [ICD-11: 9C61] | Q15822 | CHRNA2 |
| T55815 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | Q15822 | CHRNA2 |
| T55815 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | Q15822 | CHRNA2 |
| T86271 | DI0285 | Myelopathy | [ICD-11: 8B42] | Q9H2S1 | KCNN2 |
| T82543 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P17787 | CHRNB2 |
| T08499 | DI0087 | Chronic pain | [ICD-11: MG30] | Q9UJ67 | APAF1 |
| T08499 | DI0167 | Gout | [ICD-11: FA25] | Q9UJ67 | APAF1 |
| T08499 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q9UJ67 | APAF1 |
| T08499 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UJ67 | APAF1 |